On February 24, 2022 BiomX Inc. (NYSE American: PHGE) ("BiomX" or the "Company"), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, reported that Jonathan Solomon, Chief Executive Officer of BiomX, will present at the 2022 Aegis Virtual Conference on February 24, 2022, the Chardan 4th Annual Microbiome Medicines Summit on March 1, 2022 and the Oppenheimer & Co. 32nd Annual Healthcare Conference on March 17, 2022 (Press release, BiomX, FEB 24, 2022, View Source [SID1234609005]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
2022 Aegis Virtual Conference – February 23-25, 2022
Date & Time:
Thursday, March 24, 2:30 PM EST
Presenter:
Jonathan Solomon
Conference registration:
Link
Chardan 4th Annual Microbiome Medicines Summit – March 1, 2022
Date & Time:
Tuesday, March 1, 8:30 AM EST
Presenter:
Conference registration:
Jonathon Solomon
Link
Oppenheimer & Co. 32nd Annual Healthcare Conference – March 15-17, 2022
Date & Time:
Thursday, March 17, 2:00 PM EST
Presenter:
Jonathan Solomon
Conference registration:
Link
Live webcasts of presentations will also be accessible through the Investors section of the Company’s website at View Source Following the events, the webcasts will be archived on the BiomX website.